Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V M Richon

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|April 11, 1997
Regulation and expression of retinoblastoma proteins p107 and p130 during 3T3-L1 adipocyte differentiationV M Richon, R E Lyle, R E McGehee
Blood Cells, Molecules & Diseases|May 19, 2001
Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancersV M Richon, X Zhou, R A Rifkind, et al.
Molecular and Cellular Biology|November 1, 1994
Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cellsH Kiyokawa, V M Richon, R A Rifkind, et al.
Current Opinion in Oncology|October 24, 2001
Histone deacetylase inhibitors as new cancer drugsP A Marks, V M Richon, R Breslow, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|April 10, 1999
Hybrid polar inducers of transformed cell differentiation/apoptosis. From the cell to the clinicP A Marks, V M Richon, R Breslow, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 1994
Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent processP A Marks, V M Richon, H Kiyokawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2001
Cloning and characterization of a histone deacetylase, HDAC9X Zhou, P A Marks, R A Rifkind, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2000
Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5X Zhou, V M Richon, R A Rifkind, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
Inhibitors of histone deacetylase are potentially effective anticancer agentsP A Marks, R A Rifkind, V M Richon, et al.
Oncogene|February 1, 1989
Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiationV M Richon, R G Ramsay, R A Rifkind, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|April 11, 1997
Regulation and expression of retinoblastoma proteins p107 and p130 during 3T3-L1 adipocyte differentiationV M Richon, R E Lyle, R E McGehee
Blood Cells, Molecules & Diseases|May 19, 2001
Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancersV M Richon, X Zhou, R A Rifkind, et al.
Molecular and Cellular Biology|November 1, 1994
Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cellsH Kiyokawa, V M Richon, R A Rifkind, et al.
Current Opinion in Oncology|October 24, 2001
Histone deacetylase inhibitors as new cancer drugsP A Marks, V M Richon, R Breslow, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|April 10, 1999
Hybrid polar inducers of transformed cell differentiation/apoptosis. From the cell to the clinicP A Marks, V M Richon, R Breslow, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 1994
Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent processP A Marks, V M Richon, H Kiyokawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2001
Cloning and characterization of a histone deacetylase, HDAC9X Zhou, P A Marks, R A Rifkind, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2000
Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5X Zhou, V M Richon, R A Rifkind, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
Inhibitors of histone deacetylase are potentially effective anticancer agentsP A Marks, R A Rifkind, V M Richon, et al.
Oncogene|February 1, 1989
Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiationV M Richon, R G Ramsay, R A Rifkind, et al.
Pageof 5